Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

5articles mentioning drugs

7drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: ICS/LABA ×

ICS/LABA

This drug is selected. Its supporting articles are shown below.

Articles mentioning ICS/LABA

5 articles · page 1 of 1

P294 The BETRI study: preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with medium-strength inhaled corticosteroid/long-acting beta-agonists (ICS/LABA) and switching to high-strength ICS/LABA or medium-strength beclomethasone/formoterol/glycopyrronium (BDP/FF/G)

thoraxjnl · abstract · 2025-11-02 · 2 matching annotations

87.2%

msBDP/FF/G hsICS/LABA msICS/LABA SABA ICS/LABA

…ence of allergy diagnosis (52.5% vs 53.6%). Patients prescribed msBDP/FF/G were older than those prescribed hsICS/LABA (mean±standard devi…

S132 Achieving asthma remission with extrafine beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide (BDP/FF/GB) pMDI in adults with moderate-to-severe asthma: a post-hoc analysis of the TRIMARAN and TRIGGER Studies

thoraxjnl · abstract · 2025-11-02 · 2 matching annotations

81.5%

TRIMARAN BDP/FF BDP/FF/GB ICS/LABA asthma Virchow JC et al

…Is) were calculated from a logistic regression model.Results In TRIMARAN, 174 (30.2%) and 147 (25.6%) patients met all remission criteri…

P119 Implementing inhaler recycling schemes – experience within a large UK NHS trust

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

80.0%

SABA pMDI ICS/LABA Chiesi Limited Grundon Waste Management Ltd Leeds Teaching Hospitals NHS Trust

…e pMDIs. The most common class of inhaler device collected were SABA (1,127), ICS/LABA (474), and ICS/LABA/LAMA inhalers (445). The …

P295 Treatment with extrafine formulation single-inhaler triple therapy improves health-related quality of life and asthma control – results from the TriMaximize UK study

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

78.4%

glycopyrronium beclometasone formoterol BDP/FF/G LAMA ICS ICS/LABA asthma

…er triple therapy (SITT) consisting of beclometasone/formoterol/glycopyrronium (BDP/FF/G) in patients with asthma has been demonstrated in ran…

P298 Time course of exacerbation reduction with extrafine beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide (BDP/FF/GB) pMDI in adults with moderate to severe asthma: a post-hoc analysis of the TRIMARAN and TRIGGER studies

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

78.2%

TRIMARAN TRIGGER LAMA BDP/FF BDP/FF/GB ICS/LABA

…equent 8 months (period 4–12 months) was of 30.5% and 24.1%, in TRIMARAN and TRIGGER, respectively (RR of 0.695, 95% CI 0.501–0.965, p=0…